Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.99%
1,093.81
+10.77
+0.99%
1,083.041,082.631,099.011,080.59
SIXC
Communications
SIXC
Communications
SIXC
+1.06%
608.77
+6.39
+1.06%
602.38602.38609.75599.75
SIXE
Energy
SIXE
Energy
SIXE
+0.96%
1,254.81
+11.98
+0.96%
1,242.831,229.311,258.881,220.51
SIXI
Industrials
SIXI
Industrials
SIXI
+2.76%
1,761.11
+47.29
+2.76%
1,713.821,715.471,763.111,715.47
SIXM
Financials
SIXM
Financials
SIXM
+0.40%
642.58
+2.59
+0.40%
639.99636.98644.04631.81
SIXR
Staples
SIXR
Staples
SIXR
+1.63%
851.13
+13.67
+1.63%
837.46840.30852.55840.30
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.76%
217.98
+3.76
+1.76%
214.22214.22218.25214.05
SIXT
Technology
SIXT
Technology
SIXT
+0.23%
3,211.83
+7.45
+0.23%
3,204.383,215.043,217.443,159.90
SIXU
Utilities
SIXU
Utilities
SIXU
+2.55%
948.98
+23.60
+2.55%
925.38927.91949.76927.91
SIXV
Health care
SIXV
Health care
SIXV
+2.20%
1,474.52
+31.81
+2.20%
1,442.711,443.011,477.901,443.01
SIXY
Discretionary
SIXY
Discretionary
SIXY
+1.30%
2,392.12
+30.78
+1.30%
2,361.342,391.002,399.182,354.52
002399:SHE
Shenzhen Hepalink Pharma Group Co Ltd
CN¥10.87
+0.93%
(+0.100) 1D
Apr 30, 3:04:33 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002399...
Open
CN¥10.82
High
CN¥11.04
Low
CN¥10.82
Mkt. cap
14.36B
Avg. vol.
4.30M
Volume
4.49M
P/E ratio
45.64
52-wk high
CN¥14.34
52-wk low
CN¥10.30
EPS
CN¥0.24
Shares outstanding
1.25B
No. of employees
2K
News stories
From sources across the web
About Shenzhen Hepalink Pharma Group Co Ltd
CEO-
Employees2.15K
FoundedApr 21, 1998
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.42B
1.38B
1.28B
-
Cost of goods sold
974.82M
884.21M
900.40M
-
Cost of revenue
974.82M
884.21M
900.40M
-
Research and development expenses
62.72M
73.11M
50.33M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
187.36M
216.50M
252.73M
-
Operating expense
274.56M
291.36M
336.08M
-
Total operating expenses
1.25B
1.18B
1.24B
-
Operating income
173.71M
201.54M
48.03M
-
Other non operating income
-68.37M
182.67M
-254.18M
-
EBT including unusual items
305.40M
157.96M
-239.36M
-
EBT excluding unusual items
293.42M
188.04M
-97.72M
-
Income tax expense
40.39M
26.52M
-29.37M
-
Effective tax rate
13.23%
16.79%
12.27%
-
Other operating expenses
17.86M
6.60M
16.33M
-
Net income
265.26M
131.73M
-204.09M
-
Net profit margin
18.64%
9.57%
-15.89%
14.09%
Earnings per share
-
-
-
-
Interest and investment income
-
33.52M
-
-
Interest expense
-26.47M
-15.15M
-32.17M
-
Net interest expenses
-26.47M
18.37M
-32.17M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
251.05M
271.82M
128.19M
-
Gain or loss from assets sale
-1.29M
1.29M
-1.84M
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more